Penumbra Inc (PEN)
244.84
+4.35
(+1.81%)
USD |
NYSE |
Nov 22, 16:00
244.84
0.00 (0.00%)
After-Hours: 20:00
Penumbra Total Liabilities (Quarterly): 374.84M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 374.84M |
| June 30, 2024 | 373.33M |
| March 31, 2024 | 376.31M |
| December 31, 2023 | 377.36M |
| September 30, 2023 | 364.24M |
| June 30, 2023 | 365.99M |
| March 31, 2023 | 370.83M |
| December 31, 2022 | 372.03M |
| September 30, 2022 | 347.85M |
| June 30, 2022 | 357.88M |
| March 31, 2022 | 342.27M |
| December 31, 2021 | 290.32M |
| September 30, 2021 | 288.64M |
| June 30, 2021 | 236.84M |
| March 31, 2021 | 190.35M |
| December 31, 2020 | 185.20M |
| September 30, 2020 | 190.59M |
| June 30, 2020 | 157.04M |
| March 31, 2020 | 176.12M |
| December 31, 2019 | 180.29M |
| Date | Value |
|---|---|
| September 30, 2019 | 147.23M |
| June 30, 2019 | 130.93M |
| March 31, 2019 | 132.13M |
| December 31, 2018 | 92.59M |
| September 30, 2018 | 91.72M |
| June 30, 2018 | 74.12M |
| March 31, 2018 | 74.79M |
| December 31, 2017 | 76.26M |
| September 30, 2017 | 75.26M |
| June 30, 2017 | 44.02M |
| March 31, 2017 | 44.89M |
| December 31, 2016 | 41.71M |
| September 30, 2016 | 43.42M |
| June 30, 2016 | 36.39M |
| March 31, 2016 | 37.07M |
| December 31, 2015 | 31.33M |
| September 30, 2015 | 30.74M |
| June 30, 2015 | 28.70M |
| December 31, 2014 | 133.75M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
157.04M
Minimum
Jun 2020
377.36M
Maximum
Dec 2023
295.92M
Average
345.06M
Median
Total Liabilities (Quarterly) Benchmarks
| Boston Scientific Corp | 17.12B |
| Repligen Corp | 813.96M |
| Inari Medical Inc | 262.48M |
| Bruker Corp | 4.270B |
| QuidelOrtho Corp | 3.614B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.479B |
| Shareholders Equity (Quarterly) | 1.104B |
| Current Ratio | 5.821 |